posted on 2017-03-10, 12:42authored byD. Adlam, M. Peake
[First paragraph] Clinical medicine and medical research have long occupied disease-specific specialties. A visitor to any hospital or university in a developed country will likely find a cardiology department or an institute of cancer research but frequently these are widely separated or even in different buildings. This is reflected in clinical research where cancer is a frequent exclusion criteria from cardiovascular trials and likewise patients with established heart disease are often routinely excluded from cancer studies. As a result our understanding of how cancer, cardiovascular disease and their treatments interact remains relatively limited. This is despite the fact that improved treatments for both conditions have resulted in substantially improved survival rates and as a result, an ever larger population of patients will now experience both conditions in their lifetime.
Funding
Dr Adlam and Professor Peake lead the VICORI initiative co-funded by the British Heart Foundation and Cancer Research UK. Support is additionally acknowledged from the Department of Cardiovascular Medicine at the University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Unit
History
Citation
European Heart Journal - Quality of Care and Clinical Outcomes, 2017,
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences
Version
AM (Accepted Manuscript)
Published in
European Heart Journal - Quality of Care and Clinical Outcomes
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.